Author

J. Delgado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Bataller· 1 shared A. G. Pockley· 1 shared A. Lopez-Guillermo· 1 shared A. M. Garcia-Sancho· 1 shared A. Orfao· 1 shared A. P. Barker· 1 shared A. Queiros· 1 shared A. Rill-Hinarejos· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Bataller

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Integrative single-cell multi-omics of CD19CARpos and CARneg T cells suggest drivers of immunotherapy response in B-cell neoplasias

M. Guerrero-Murillo, A. Rill-Hinarejos, J. L. Trincado, A. Bataller, V. Ortiz-Maldonado, D. Benitez-Ribas, M. Espanol, E. A. Gonzalez, N. Martinez-Cibrian, D. Marchese, L. Martin-Martin, A. M. Garcia-Sancho, H. Heyn, M. Juan, A. Urbano-Ispizua, , P. Menendez

This study integrates single-cell multi-omics data from CAR-T cells to identify factors influencing immunotherapy response in B-cell neoplasias.

bioRxiv · Jan 23, 2024 · PreprintImmunology

Reduced Monocyte Proportions and Responsiveness in Convalescent COVID-19 Patients

E. Ravkov, E. S. C. P. Williams, M. Elgort, A. Spivak, A. P. Barker, V. Planelles, J. Delgado, L. Lin, T. Hanley

This study shows that SARS-CoV-2 infection reduces monocyte subsets and their functional responses in convalescent patients compared to uninfected controls.

bioRxiv · Oct 25, 2023Immunology

SARS-CoV-2 spike RBD and nucleocapsid encoding DNA vaccine elicits T cell and neutralising antibody responses that cross react with variants

V. A. Brentville, M. Vankemmelbeke, R. L. Methingham, P. Symonds, K. W. Cook, R. A. Urbanowicz, T. Tsoleridis, C. M. Coleman, K.-C. Chang, A. Skinner, E. Dubinina, I. Daniels, S. Shah, M. Argonza, J. Delgado, , L. G. Durrant

This paper designs a DNA vaccine encoding SARS-CoV-2 spike RBD and nucleocapsid proteins, showing strong T cell responses and cross-reactive neutralizing antibodies against variants in mice.

bioRxiv · Jun 18, 2021 · PreprintImmunology

The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

M. Duran-Ferrer, G. Clot, F. Nadeu, R. Beekman, T. Bauman, J. Nordlund, Y. Marincevic-Zuniga, G. Lonnerholm, A. Rivas, S. Martin, R. Ordonez, G. Castellano, M. Kulis, A. Queiros, L. Seung-Tae, , J. I. Martin-Subero

This study analyzes DNA methylation in B-cell tumors to show its relation to proliferative history and clinical outcomes, introducing a new mitotic clock for prognosis.

bioRxiv · Feb 6, 2020Cancer Biology